243 related articles for article (PubMed ID: 31744820)
1. Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.
Kaymak I; Maier CR; Schmitz W; Campbell AD; Dankworth B; Ade CP; Walz S; Paauwe M; Kalogirou C; Marouf H; Rosenfeldt MT; Gay DM; McGregor GH; Sansom OJ; Schulze A
Cancer Res; 2020 Jan; 80(2):189-203. PubMed ID: 31744820
[TBL] [Abstract][Full Text] [Related]
2. An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
Longo J; Mullen PJ; Yu R; van Leeuwen JE; Masoomian M; Woon DTS; Wang Y; Chen EX; Hamilton RJ; Sweet JM; van der Kwast TH; Fleshner NE; Penn LZ
Mol Metab; 2019 Jul; 25():119-130. PubMed ID: 31023626
[TBL] [Abstract][Full Text] [Related]
3. p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.
Moon SH; Huang CH; Houlihan SL; Regunath K; Freed-Pastor WA; Morris JP; Tschaharganeh DF; Kastenhuber ER; Barsotti AM; Culp-Hill R; Xue W; Ho YJ; Baslan T; Li X; Mayle A; de Stanchina E; Zender L; Tong DR; D'Alessandro A; Lowe SW; Prives C
Cell; 2019 Jan; 176(3):564-580.e19. PubMed ID: 30580964
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.
Freed-Pastor WA; Mizuno H; Zhao X; Langerød A; Moon SH; Rodriguez-Barrueco R; Barsotti A; Chicas A; Li W; Polotskaia A; Bissell MJ; Osborne TF; Tian B; Lowe SW; Silva JM; Børresen-Dale AL; Levine AJ; Bargonetti J; Prives C
Cell; 2012 Jan; 148(1-2):244-58. PubMed ID: 22265415
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of eIF2α attenuates statin-induced apoptosis by inhibiting the stabilization and translocation of p53 to the mitochondria.
Lee SK; Kim YS
Int J Oncol; 2013 Mar; 42(3):810-6. PubMed ID: 23354132
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.
Pandyra AA; Mullen PJ; Goard CA; Ericson E; Sharma P; Kalkat M; Yu R; Pong JT; Brown KR; Hart T; Gebbia M; Lang KS; Giaever G; Nislow C; Moffat J; Penn LZ
Oncotarget; 2015 Sep; 6(29):26909-21. PubMed ID: 26353928
[TBL] [Abstract][Full Text] [Related]
7. Metabolic control of YAP and TAZ by the mevalonate pathway.
Sorrentino G; Ruggeri N; Specchia V; Cordenonsi M; Mano M; Dupont S; Manfrin A; Ingallina E; Sommaggio R; Piazza S; Rosato A; Piccolo S; Del Sal G
Nat Cell Biol; 2014 Apr; 16(4):357-66. PubMed ID: 24658687
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
Pereira M; Glogova A; Haagsma J; Stewart J; Shepherd TG; Petrik J
J Ovarian Res; 2023 Nov; 16(1):218. PubMed ID: 37986175
[TBL] [Abstract][Full Text] [Related]
9. The interplay between mutant p53 and the mevalonate pathway.
Parrales A; Thoenen E; Iwakuma T
Cell Death Differ; 2018 Mar; 25(3):460-470. PubMed ID: 29238070
[TBL] [Abstract][Full Text] [Related]
10. USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer.
Maier CR; Hartmann O; Prieto-Garcia C; Al-Shami KM; Schlicker L; Vogel FCE; Haid S; Klann K; Buck V; Münch C; Schmitz W; Einig E; Krenz B; Calzado MA; Eilers M; Popov N; Rosenfeldt MT; Diefenbacher ME; Schulze A
Cell Death Differ; 2023 Jul; 30(7):1710-1725. PubMed ID: 37202505
[TBL] [Abstract][Full Text] [Related]
11. Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence.
Wei S; Liu L; Chen Z; Yin W; Liu Y; Ouyang Q; Zeng F; Nie Y; Chen T
J Cell Mol Med; 2020 Jan; 24(1):276-284. PubMed ID: 31746143
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells.
Lafita-Navarro MC; Venkateswaran N; Kilgore JA; Kanji S; Han J; Barnes S; Williams NS; Buszczak M; Burma S; Conacci-Sorrell M
PLoS Genet; 2020 Nov; 16(11):e1009117. PubMed ID: 33201894
[TBL] [Abstract][Full Text] [Related]
13. Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.
Greenaway JB; Virtanen C; Osz K; Revay T; Hardy D; Shepherd T; DiMattia G; Petrik J
Oncotarget; 2016 Jul; 7(30):47343-47365. PubMed ID: 27329838
[TBL] [Abstract][Full Text] [Related]
14. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.
Palozza P; Colangelo M; Simone R; Catalano A; Boninsegna A; Lanza P; Monego G; Ranelletti FO
Carcinogenesis; 2010 Oct; 31(10):1813-21. PubMed ID: 20699249
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial respiratory chain dysfunction alters ER sterol sensing and mevalonate pathway activity.
Wall CTJ; Lefebvre G; Metairon S; Descombes P; Wiederkehr A; Santo-Domingo J
J Biol Chem; 2022 Mar; 298(3):101652. PubMed ID: 35101444
[TBL] [Abstract][Full Text] [Related]
16. Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1.
He L; Ioannidis A; Hoffman CJ; Arambula E; Joshi P; Whitelegge J; Liau LM; Kornblum HI; Pajonk F
Cancer Res Commun; 2024 Jun; 4(6):1566-1580. PubMed ID: 38837899
[TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway.
Qi XF; Zheng L; Lee KJ; Kim DH; Kim CS; Cai DQ; Wu Z; Qin JW; Yu YH; Kim SK
Cell Death Dis; 2013 Feb; 4(2):e518. PubMed ID: 23449454
[TBL] [Abstract][Full Text] [Related]
18. Efficient use of exogenous isoprenols for protein isoprenylation by MDA-MB-231 cells is regulated independently of the mevalonate pathway.
Onono F; Subramanian T; Sunkara M; Subramanian KL; Spielmann HP; Morris AJ
J Biol Chem; 2013 Sep; 288(38):27444-27455. PubMed ID: 23908355
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-874 targets phosphomevalonate kinase and inhibits cancer cell growth via the mevalonate pathway.
Aersilan A; Hashimoto N; Yamagata K; Yokoyama M; Nakayama A; Shi X; Nagano H; Sakuma I; Nohata N; Kinoshita T; Seki N; Rahmutulla B; Kaneda A; Zhahara SN; Gong Y; Nishimura M; Kawauchi S; Kawakami E; Tanaka T
Sci Rep; 2022 Nov; 12(1):18443. PubMed ID: 36323841
[TBL] [Abstract][Full Text] [Related]
20. Targeting mutant p53 through the mevalonate pathway.
Freed-Pastor W; Prives C
Nat Cell Biol; 2016 Oct; 18(11):1122-1124. PubMed ID: 27784901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
